The use of well-characterized sera for the assessment of new diagnostic enzyme-immunoassays for the diagnosis of heparin-induced thrombocytopenia.
Warkentin
T E
TE
Sheppard
J I
JI
Moore
J C
JC
Kelton
J G
JG
D000925:Anticoagulants / Q000009:adverse effects* / Q000276:immunology; D006493:Heparin / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D007124:Immunoenzyme Techniques; D007074:Immunoglobulin G / Q000097:blood*; D010978:Platelet Factor 4 / Q000276:immunology*; D011237:Predictive Value of Tests; D012372:ROC Curve; D011933:Reagent Kits, Diagnostic; D012680:Sensitivity and Specificity; D013921:Thrombocytopenia / Q000139:chemically induced / Q000175:diagnosis* / Q000276:immunology
D000925:Anticoagulants; D007074:Immunoglobulin G; D011933:Reagent Kits, Diagnostic; D010978:Platelet Factor 4; D006493:Heparin